Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GMP comment period extended

This article was originally published in The Tan Sheet

Executive Summary

The public comment period on a proposed rule allowing exemptions from 100 percent identity testing requirements in the dietary supplements good manufacturing practices final rule is extended to Oct. 24, FDA says in a Sept. 17 Federal Register notice. FDA responded to requests from parties calling for more time to comment. FDA published the testing exemption IFR and the GMP final rule in June (1"The Tan Sheet" June 25, 2007, p. 3)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100909

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel